Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.

Vaccine · 2023 · PMC10266501 · PMID 37344261

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally statistically significantno p-value reported

After adjusting for seasonality and exclusion of cases with prior COVID-19 infection, a marginally statistically significant elevation in risk was observed following the BNT162b2 booster dose (IRR: 1.06, 95 % CI: 1.003 to 1.12).

also in 358 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.